Frontotemporal dementia and parkinsonism linked to chromosome 17 - the first Polish family

European Journal of Neurology

Volumn 18, Issue 3, 2011, Pages 535-537

  Narozdanska E ^a,b   Jasinska Myga, B ^c,d   Sitek, E J ^a,b   Robowski, P ^a,b   Brockhuis, B ^b   Lass, P ^b   Dubaniewicz, M ^b   Wieczorek, D ^b   Baker, M ^e   Rademakers, R ^e   Wszolek, Z K ^c   Slawek J ^a,b  

^a ST ADALBERT HOSPITAL   (Poland)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c MAYO CLINIC   (United States)

^d MEDICAL UNIVERSITY OF SILESIA   (Poland)

^e MAYO GRADUATE SCHOOL   (United States)

Author keywords

FTDP 17; MAPT; P301L mutation

Indexed keywords

FOLIC ACID; TAU PROTEIN;

ADULT; ARTICLE; CHROMOSOME 17; CHROMOSOME MUTATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLIC ACID BLOOD LEVEL; FRONTOTEMPORAL DEMENTIA; HUMAN; MALE; NEUROPSYCHOLOGY; PARKINSONISM; PRIORITY JOURNAL; TREMOR;

ADULT; BRAIN; CHROMOSOMES, HUMAN, PAIR 17; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMANS; MALE; MIDDLE AGED; MUTATION; PEDIGREE; POLAND; TAU PROTEINS;

EID: 79951619724     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2010.03107.x     Document Type: Article

References (12)

1. Foster NL, Wilhelmsen K, Sima AAF, et al. Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference. Ann Neurol 1997; 41: 706-715.
2. Poorkaj P, Bird TD, Wijsman E, et al. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol 1998; 43: 815-825.
3. Baker M, Mackenzie IR, Pickering-Brown SM, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 2006; 442: 916-919.
4. Baba Y, Tsuboi Y, Baker MC, et al. The effect of tau genotype on clinical features in FTDP-17. Parkinsonism Relat Disord 2005; 11: 205-208.
5. Reed LA, Wszolek ZK, Hutton M. Phenotypic correlations in FTDP-17. Neurobiol Aging 2001; 22: 89-107.
6. Sitek EJ, Narozanska E, Slawek J, et al. Unilateral neglect in a patient diagnosed with frontotemporal dementia and parkinsonism linked to chromosome 17. Acta Neuropsychiatr 2009; 21: 4.
7. Bird TD, Nochlin D, Poorkaj P, et al. A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L). Brain 1999; 122: 741-756.
8. Wszolek ZK, Lynch T, Wilhelmsen KC. Rapidly progressive autosomal dominant parkinsonism and dementia with Pallido-Ponto-Nigral Degeneration (PPND) and Disinhibition-Dementia-Parkinsonism-Amyotrophy Complex (DDPAC) are clinically distinct conditions that are both linked to 17q21-22. Parkinsonism Relat Disord 1997; 3: 67-76.
9. Pal PK, Wszolek ZK, Uitti R, et al. Positron emission tomography of dopamine pathways in familial parkinsonian syndromes. Parkinsonism Relat Disord 2001; 8: 51-56.
10. Wszolek ZK, Markopoulou K. Molecular genetics of familial parkinsonism. Parkinsonism Relat Disord 1999; 5: 145-155.
11. Bhalearo J, Bowcock AM. The genetics of psoriasis: a complex disorder of the skin and immune system. Hum Mol Genet 1998; 7: 1537-1545.
12. Goris A, Maranian M, Walton A, et al. No evidence for association of a European-specific chromosome 17 inversion with multiple sclerosis. Eur J Hum Genet 2006; 14: 1064.